Llwytho...
Huperzine A for mild cognitive impairment
BACKGROUND: Mild cognitive impairment (MCI) has been proposed as a condition of intermediate symptomatology between the cognitive changes of ageing and fully developed symptoms of dementia. Treatment in the stages of MCI may delay the deterioration of cognitive impairment and delay the progression t...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cochrane Database Syst Rev |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley & Sons, Ltd
2012
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6464949/ https://ncbi.nlm.nih.gov/pubmed/23235666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD008827.pub2 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|